• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Genetics of alcohol-related hepatocellular carcinoma - its role in risk prediction

    2020-07-21 09:39:14KenLiuGontranVersetEricTrepoDevanshiSeth
    Hepatoma Research 2020年7期

    Ken Liu, Gontran Verset, Eric Trepo, Devanshi Seth,5

    1Centenary Institute of Cancer Medicine and Cell Biology, The University of Sydney, Sydney, NSW 2006, Australia.

    2Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.

    3Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB H?pital Erasme, Université Libre de Bruxelles, Brussels 1070, Belgium.

    4Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Brussels 1070, Belgium.

    5Drug Health Services, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW 2050, Australia.

    Abstract Hepatocellular carcinoma (HCC) is the most common primary liver malignancy, with increasing incidence worldwide. Alcohol-related cirrhosis (AC) accounts for 30% of the global incidence of HCC and HCC-related deaths. With the decline of hepatitis C virus (HCV) and decreasing HCV-related HCC, AC will soon become the leading cause of HCC. Excess alcohol consumption (> 80 g per day for > 10 years) increases the risk of HCC by 5-fold. However, only up to 35% of excessive drinkers develop cirrhosis and its associated HCC risk. Individual variation in susceptibility to HCC is known, but there is limited information to predict who among the patients is at high risk of progressing to HCC. Clinical risk factors for HCC include male gender, older age, severity of cirrhosis, obesity and presence of type 2 diabetes. In addition to ethnic variability in HCC risk, genetic variants are known to alter the risk of alcohol-related HCC. For example, single nucleotide polymorphisms in PNPLA3(rs738409, C>G) and TM6SF2 (rs58542926, C>T) increase the risk of AC-related HCC, whereas HSD17B13(T>A) reduces the risk for HCC. Studies have also confirmed PNPLA3 and TM6SF2 to be independent risk factors for AC-related (but not HCV-related) HCC. Combining genetic risk factors with phenotypic/clinical risk factors has been explored for stratification of patients for HCC development. Risk allele rs378409-G in PNPLA3 when combined with phenotypic/clinical risk factors (BMI, age, sex) has enabled HCC risk stratification of AC patients into low-, intermediate- and high-risk subgroups. Similarly, a combination of the two genetic variants PNPLA3-G and TM6SF2-T has been independently associated with risk of HCC onset. Using a polygenic risk score approach of incorporating several genetic variants, prognostic performance of polygenic risk score that included PNPLA3 rs378409 and TM6SF2 rs58542926 improved HCC prediction better than with either variant alone. Incorporating new variants and risk factors has the potential to build better algorithms/models to predict onset, early diagnosis and treatments for AC-related HCC. However, clinical usefulness of these approaches is yet to be determined.

    Keywords: Alcohol-related cirrhosis, PNPLA3, HSD17B13, TM6SF2, risk prediction

    INTRODUCTION

    Hepatocellular carcinoma (HCC) is the most common primary liver malignancy, with increasing incidence worldwide[1]. Despite screening programs in high-risk populations, long-term outcome is poor with a 5-year survival of 18%, representing the world’s third most lethal cancer. More specifically, the World Health Organization estimates that more than a million patients will die from liver cancer in 2030[2].

    In almost 90% of cases, HCC occurs in the context of chronic liver disease, in particular, on the background of cirrhosis[1,3]. The underlying chronic liver disease promoting liver carcinogenesis varies geographically[1].In Asia and sub-Saharan Africa, HCC is mostly caused by hepatitis B virus infection, while in the United States and Europe the current leading etiologies are hepatitis C virus (HCV) infection and alcohol-related cirrhosis (AC) followed by non-alcohol-related fatty liver disease (NAFLD)[4]. However, the advent of new direct-acting antiviral agents is expected to control HCV-related HCC in upcoming years, and AC will soon become the leading cause of HCC in most high-income countries[1]. Clinical risk factors for HCC occurrence include male gender, older age, severity of cirrhosis, obesity and presence of type 2 diabetes[5-7].Clinical risk models have shown that the individual risk of HCC development is highly variable[6]. In addition, case-control and cancer database studies have highlighted the impact of ethnic background and a significant familial clustering[8,9]. For example, individuals of African and Hispanic ancestry are less likely to undergo curative therapies[10]. Overall, these observations strongly suggest that inherited genetic factors contribute to hepatocarcinogenesis.

    Here, we review the current literature on risk factors, with a particular focus on genetic risk variants for alcohol-related HCC occurrence.

    EPIDEMIOLOGY AND CHARACTERISTICS OF ALCOHOL-RELATED HCC

    Alcohol-related HCC occurs infrequently in patients without pre-existing cirrhosis. Cirrhosis (of any etiology) is the single biggest risk factor for HCC development[3,11,12]. The annual incidence of HCC in patients with AC is nearly 3%[13]. The risk of developing AC and HCC parallels the amount of alcohol consumed daily and significantly increases above a threshold of 20 and 30 g for females and males,respectively[14,15]. Heavy alcohol drinking of more than 80 g per day for longer than 10 years increases the risk of HCC by 5-fold[16]. More specifically, AC accounts for 30% of the global incidence of HCC and HCCrelated deaths, with marked geographical differences[17]. In Europe, HCC occurrence on the background of alcohol-related liver disease (ALD) varies from 20% in the south (e.g., Italy or Spain), to 63% in eastern countries. In the United States, alcohol accounts for 13% to 23% of HCC cases. Finally, the prevalence of alcohol-related HCC reaches 6% in the Middle East and 14% in North Africa[17,18]. The influence of alcohol consumption has also been highlighted by the impact of alcohol withdrawal on HCC development. Thus, a meta-analysis reported an annual reduction of HCC risk by 6%-7%[19].

    However, only up to 10%-35% of excessive drinkers develop advanced fibrosis or cirrhosis and its associated HCC risk[20]. Interestingly, the role of alcohol consumption seems to be milder or even negligible compared to other environmental factors in the setting of HCC occurring in a non-fibrotic liver. For example, a recent case-control study observed that after adjustment of smoking habits and metabolic syndrome features,alcohol consumption was no longer independently associated with HCC in individuals with F0-F1 fibrosis stage[21].

    HCC is often diagnosed at a later Barcelona Clinic Liver Cancer (BCLC) stage in patients with ALD and with a more severe underlying cirrhosis leading to a worse prognosis compared to other liver diseases[14,22].A previous study reported that patients with alcohol-related HCC are often younger and are more frequently diagnosed with a multifocal or infiltrative/massive tumor compared to HCV-related HCC.However, this apparent greater cancer aggressiveness disappeared after adjusting for confounding factors,and prognosis was similar in ALD and HCV patients when stratified by BCLC stages[23]. Moreover, a recent study did not show significant differences in tumor characteristics between patients with AC- and NAFLD-related HCC[24]. Overall, the higher proportion of advanced BCLC stages observed in ALD/AC patients might only reflect a lower compliance with surveillance programs, rather than a greater tumor aggressiveness.

    LIMITATIONS OF SCREENING STRATEGIES IN PATIENTS WITH AC-RELATED HCC

    The American Association for the Study of Liver Diseases and European Association for the Study of the Liver recommend HCC surveillance in all cirrhotic patients using ultrasound, with or without alphafetoprotein determination, every 6 months[25,26]. This surveillance program has been shown to increase overall survival and improve the quality-adjusted life expectancy[27,28]. However, this periodic surveillance has been shown to be difficult to implement in daily clinical practice, ultimately leading to a significant prevalence of HCC detected at a more advanced stage[29]. Thus, more than 20% of HCC patients are also diagnosed with an unsuspected cirrhosis[30]. This phenomenon is even more pronounced in patients with ALD because AC is underdiagnosed due to their poor compliance in cancer surveillance programs[30].Therefore, risk factors identified for AC are potential candidates for susceptibility to HCC.

    Due to the aforementioned limitations, there is an urgent need for new detection strategies and the development of new highly sensitive, reliable, and easily accessible biomarkers that can either improve the early detection of HCC in high-risk patients with AC or identify individuals at risk of progressive ALD when liver fibrosis is incomplete and potentially reversible[31].

    Individual variation in susceptibility to HCC is known, but there is limited information to predict who among the patients is at high risk of progressing to HCC. A better understanding of the contributing molecular, genetic and epigenetic factors is required to identify drivers of and therapeutic options for hepatocarcinogenesis.

    CONTRIBUTION OF GENETIC VARIANTS TO THE PREDICTION OF ALCOHOL-RELATED HCC

    The association of genetic variants with the risk of alcohol-related HCC has been reported. Earlier studies targeted genes with known functions, specifically genes known to operate in the pathogenesis of ALD and recently proposed to be part of a “5-hit working model” of disease progression leading to HCC[32]. These candidate genes, involved in hepatic alcohol metabolism [alcohol dehydrogenase (ADH), acetaldehyde dehydrogenase (ALDH), ethanol-induced cytochrome P450 (CYP2E1), CYP2E1-dependent microsomal ethanol oxidizing system (MEOS)] and affecting downstream mechanisms including oxidative stress[CYP2E1, glutathione S-transferase (GST), manganese superoxide dismutase (MnSOD),N-acetyltransferase 2, ectonucleotide pyrophosphatase/phosphodiesterase 1, homeostatic iron regulator (HFE)], endotoxin release [CD14, toll-like receptor 4 (TLR4)], immune function (TNFα, IFNγ, IL-10, IL-1B, CD14) and fibrogenesis [TGFβ, angiotensin, leptin, metalloproteinases (MMPs), tissue inhibitors of MMPs (TIMPs)],have been extensively reviewed for their association to alter risk of ALD/AC and ALD-related HCC[12,33-35].But results from most of these earlier studies could not be replicated or confirmed due to limitations in technology, small sample size, inappropriate study population and not accounting for underlying ethnic variability. The most widely known genetic mutations altering the risk of ALD and ALD-HCC are in the alcohol-metabolizing enzymes. These mutations alter the enzyme kinetics of alcohol dehydrogenase (ADH)and acetaldehyde dehydrogenase (ALDH)[35,36]. ADH1B rs1229984 induces ADH activity and acetaldehyde formation, whereas ALDH2?2 rs671 reduces ALDH activity, impairing its ability to clear acetaldehyde[35,37].Carriage of both mutations results in the accumulation of toxic acetaldehyde levels with intense rise in arterial blood flow to the face, causing the well-known flushing and nausea. In East Asian populations with high prevalence of these mutations, this may result in reduced alcohol intake conferring protection against alcoholism[38]. Conversely, the risk of developing ALD and ALD-HCC increases in drinkers who carry one or both mutations[36].

    Recent technological advances such as genome-wide association studies (GWAS) and next-generation sequencing have added to the growing field of genetic and epigenetic factors that modulate the risk for ALD/AC-related HCC. In recent years, a few single nucleotide polymorphisms (SNPs) have been discovered that are associated with risk of AC[39-41]. The single most commonly reproduced association with liver cirrhosis is the rs738409 SNP (p. I148M) in patatin-like phospholipase domain protein 3(PNPLA3),which is also associated with increased HCC risk[42]. This C>G mutation is accompanied by a change from isoleucine to methionine at a conserved amino acid residue (I148M). Association of rs738409 (C>G) with increased risk of liver diseases has been confirmed in AC[40,41]and alcohol-related HCC[43,44]. Dose effect of the G-allele has been shown with ancestry-adjusted odds ratio (OR) increasing by 1.79 per G allele(P= 1.9 × 10-5) for ALD risk[45]and 1.77 (95%CI: 1.42-2.19,P= 2.78 × 10-7) per G allele for HCC[46].The influence of this variant on HCC risk prediction revealed that the rs738409 (GG) genotype was an independent risk factor specifically for alcohol- (but not HCV-) related HCC[46]. Moreover, OR among the AC patients with HCC increased from 2.87 (95%CI: 1.61-5.10) in carriers of the CG genotype to 12.41(95%CI: 6.99-22.03) in GG patients[43].

    A study in a Chinese population showed that rs17401966 (A>G) in kinesin-like factor 1 B(KIF1B), a tumor suppressor gene, was associated with risk of HCC. The risk of HCC was higher in carriers of the AA genotype, compared to GG or AG, but only in the presence of alcohol (OR 2.36, 95%CI: 1.49-3.74),suggesting an additive gene-environment interaction between rs17401966 and alcohol consumption[47]. But this association has not been confirmed. Similarly, rs641738 (C>T) in membrane-boundO-acyltransferase 7(MBOAT7), was identified as a risk locus for AC[40], but has yet to be replicated in other studies as a risk for AC/ALD or HCC.

    Another SNP, rs58542926 (?/T) in transmembrane 6 superfamily 2(TM6SF2), is strongly associated with the risk for HCC, particularly in patients with AC- and not HCV-related cirrhosis[44,48]. This variant was independently confirmed to be associated with HCC using a multivariate model adjusted for age, sex, BMI and diabetes (OR 2.5, 95%CI: 1.4-4.3)[48].

    SNPs in hydroxysteroid 17-beta dehydrogenase 13(HSD17B13) are associated with decreased liver transaminases and liver injury[49]. In particular, recently identified splice variant SNP rs72613567 (T>A),resulting in loss of function and reduced enzyme activity, also showed (1) interactions withPNPLA3rs738409 risk allele, with each rs72613567:TA allele lowering the increase in transaminase levels conferred by eachPNPLA3risk allele (I148M); and (2) allele dose-dependent association of rs72613567:TA with decrease inPNPLA3mRNA expression[39]. Importantly, this rs72613566 (T>A) was associated with lower odds of alcohol- and non-alcohol-related liver diseases/cirrhosis as well as lower risk for HCC. The lower risk conferred by rs72613567 variant wasPNPLA3allele-dependent for AC and was confirmed in both men and women[50]. However, the rs72613567-associated lower risk for HCC wasPNPLA3-dependent only in men[50].

    It is suggested that for risk of AC/ALD-related HCC,PNPLA3may be most relevant for the development of steatosis and ALD/AC, andTM6SF2andMBOAT7contributing towards HCC through inflammationdriven fibrosis[51]. Intriguingly, SNPs reported so far inPNPLA3, HSD17B13, TM6SF2andMBOAT7as being associated with AC/ALD are involved in lipid metabolism and processing, but their role in developing AC-ALD and HCC is yet to be clarified. Further investigations are required into the contribution of genetic factors individually and in combination with other variants, especially those influencing the effect on each other, such asPNPLA3andHSD17B13. Understanding the roles of SNPs in the biology of liver disease is still in its infancy, and there is limited literature on specific functions of these recently identified SNPs.Although some SNPs are shared among different etiologies of cirrhosis and HCC, the role or interaction of these SNPs remains unclear in complex etiologies that co-exist with AC, such as viral hepatitis and NAFLD-related HCC. Further investigations are required to delineate the contribution of these SNPs to HCC development.

    RISK STRATIFICATION FOR AC/ALD-RELATED HCC

    Using a combination of genetic risk factors with other phenotypic/clinical risk factors has been explored for the identification and stratification of patients for HCC development[46,48,52-56]. Using the rs378409 risk variant inPNPLA3in combination with other phenotype/clinical factors (BMI, age, sex) enabled HCC risk stratification of low-, intermediate- and high-risk AC patients (hazard ratio (HR 4.3, 95%CI: 2.7-6.4)[53].Similarly, a combination of the two genetic variantsPNPLA3-G andTM6SF2-T was independently associated with risk of HCC onset (HR 2.3, 95%CI: 1.5-3.4)[48]. Furthermore, the same study also reported that the number of HCC cases with carriage of bothPNPLA3-G andTM6SF2-T risk alleles was significantly higher than carriers of only one risk allele in either SNP.

    Most recently, a combination of all reported SNPs in AC, rs738409 (PNPLA3), rs6834314 (HSD17B13),rs58542926 (TM6SF2) and rs626283 (MBOAT7),when added to phenotypic factors (BMI, diabetes status,wine and coffee consumption), performed better [area under the curve (AUC) 0.748, 95%CI: 0.721-0.774], compared to only genetic factors (AUC 0.689, 95%CI: 0.660-0.717) or only phenotypic factors(AUC 0.681, 95%CI: 0.651-0.710), in stratifying drinkers with AC from drinkers with no liver disease[57].It is encouraging that combining information on genetic variants with other risk factors can improve the identification of patients at risk. Furthermore, these genetic variants have also been shown to modulate severity of NAFLD (and its progression to steatohepatitis, fibrosis and cirrhosis) which commonly co-exists with alcoholic liver disease patients as “dual-etiology fatty liver disease” and accelerates liver injury[58,59].

    Recently, the approach of incorporating several genetic variants in a so-called polygenic risk score (PRS)has been shown to be a successful strategy to improve the prediction of various complex phenotypes[60].Thus, this method has been shown to outperform existing clinical models for the prediction of breast cancer with personalized recommendation on screening[61]. Of note, the addition of other risk factors into a global predictive model improves the overall performances compared to PRS alone[62]. At the transcriptional level, gene expression signatures gathering several dozens of genes (i.e., Prosigna and MammaPrint) have been included by the European Society for Medical Oncology to its clinical practice guidelines as prognostic and predictive tools to determine the benefit from chemotherapy[63].

    The use of PRS to predict HCC occurrence in AC-related HCC patients is emerging[52,64]. More specifically,the prognostic performance of PRS includingPNPLA3rs738409 andTM6SF2rs58542926 was higher than when consideringPNPLA3andTM6SF2variants alone[52,64].

    Several other SNPs have been identified as being associated with the risk of HCC, particularly with a viral etiology, but the literature is sparse regarding genetic variants specifically in relation to alcohol-related HCC. Similarly, contributions of molecular markers[65-67], somatic mutations[68], chromosomal instability and tumor microenvironment[69], and other regulatory components, such as mRNAs[70], noncoding RNAs[65,71], epigenetic[71,72]and mitoepigenetic factors[73]influencing the risk of alcohol-related HCC are few and overlap with other etiologies[69,71]. Last but not least, the role of the gut microbiota (fungi, bacteria and viruses), is another emerging factor influencing disease risk in ALD and ALD-HCC[74,75]. The gut microbiota also engages in alcohol metabolism, thereby altering the risk for ALD pathogenesis. Changes in the gut microbiome significantly correlates with alcohol consumption in human and experimental models,and there is evidence that alcohol and gut metabolites in ALD patients show carcinogenic effects[74],potentially increasing the risk of HCC.

    Genomic studies have revealed several subclasses of HCC. Alcohol-related HCC is associated withCTNNB1mutations (WNT-β-catenin signalling pathway); however, direct translation of molecular HCC subclasses into clinical management (i.e., personalized medicine) is yet to be achieved[76]. The recent success of checkpoint inhibitors in HCC has led to a renewed interest in immunological profiling of HCC and opportunities for personalized medicine. Recently, Siaet al.[77]analyzed the gene expression pattern of inflammatory cells in HCCs of almost 1000 patients. The authors identified a novel molecular class of tumors (in approximately 25% of patients) with an enriched inflammatory response characterized by overexpression of immune-related genes and high expression of PD1 and PD-L1 which may predict response to checkpoint inhibitor immunotherapy. A study by The Cancer Genome Atlas consortium performed multi-platform integrative molecular subtyping on 196 HCCs and found a similar subset of patients with high lymphocyte infiltration (in 22% of patients)[78]. Of note, the authors showed that the aforementionedCTNNB1mutation was associated with a lack of immune infiltrate (so-called cold tumors),which has been observed by others[78,79]. In a recent first report of prospective genotyping of advanced HCC by next-generation sequencing,CTNNB1mutations were associated with primary resistance to immune checkpoint inhibitors[80]. Patients exhibitingCTNNB1mutations all had progressive disease as their best response and a shorter median survival compared to those without mutations (9.1 monthsvs.15.2 months,respectively). Clearly, the immunological classification of alcohol-related HCCs will become increasingly important as immune-based therapies are added to the limited therapeutic options for patients with advanced disease.

    With the discovery of new variants and risk factors, there is the potential to incorporate them for building prediction algorithms/models for AC/ALD-HCC onset, early diagnosis and treatments.

    CLINICAL APPLICATIONS OF RISK-STRATIFIED AC/ALD-HCC PATIENTS

    In terms of clinical application, patients identified by the above genetic modifiers to be at high risk of developing significant liver fibrosis may be prioritized for early referral to specialist care, with those at low risk remaining in primary care. These select high-risk patients can then be linked with resource-intensive multidisciplinary and evidence-based care involving hepatologists, psychiatrists, and addiction specialists to maximize their chance of obtaining abstinence. Indeed, when prolonged abstinence is achieved, it has been shown to lead to resolution of steatosis and inflammation and even fibrosis regression in some (but not all) patients[81,82]. Specialist care can also facilitate access to closer monitoring of liver fibrosis using noninvasive tests (e.g., transient elastography, magnetic resonance elastography) and prompt commencement of HCC surveillance (discussed below) when patients are diagnosed with cirrhosis.

    Risk stratification for HCC surveillance

    Figure 1. Potential clinical applications of genetic-based tests in alcoholic cirrhosis and related hepatocellular carcinoma. ?It would be unethical to use genetic tests in the pre-transplant setting to determine if a patient should be offered liver transplantation. AFP: alphafetoprotein; CT: computed tomography; HCC: hepatocellular carcinoma; MRI: magnetic resonance imaging

    Aside from the prediction of patients at risk of advanced fibrosis or cirrhosis, genetic variants (e.g.,PNPLA3, TM6SF2andHSD17B13) can also help predict HCC development. As mentioned, these genes predisposing to alcohol-related HCC can be incorporated with other established risk factors for HCC(e.g., male sex, age and obesity) into a validated scoring system to risk-stratify patients for tailored HCC surveillance. Indeed, risk calculators for HCC development already exist for other liver diseases such as chronic hepatitis B and hepatitis C infection[83,84]. It is likely that the combination of several genetic variants(rather than any single SNP) with or without clinical variables into a score will be most predictive. Since the surveillance interval of 6 months for patients[85]was determined on the basis of estimated tumor doubling time (rather than tumor development risk), shortening intervals (e.g., to every 3 months) for ALD patients classified as high-risk may not result in improved outcomes[86]. However, risk calculators may help identify high-risk patients without cirrhosis, who should undergo surveillance (akin to surveillance of noncirrhotic chronic hepatitis B patients) or those who should be surveyed with a more sensitive modality (e.g.,computed tomography scan or magnetic resonance imaging). Conversely, risk scores may select out a lowrisk group of patients with ALD who can safely forego surveillance, especially in resource-poor settings[Figure 1]. The development and application of risk scores using genetics needs to be explored further.

    Given the rise of alcohol-related HCC in the post-HCV era, it is imperative that more research be conducted in this area, providing a deeper understanding of the underlying risks and early diagnosis of HCC in patients with ALD. Possibilities exist of repurposing biomarkers and therapeutic agents for alcoholrelated HCC identified/used for other etiologies.

    CHALLENGES OF CURRENT RISK PREDICTION MODELS FOR ALCOHOL-RELATED HCC

    Risk prediction for alcohol-related HCC has been critically missing in the past due to lack of reproducible genetic studies. Recent discoveries on several genetic risk associations with AC have opened the field for using this information for risk prediction, not only for cirrhosis but also for alcohol-related HCC in patients with alcohol use problems.

    The contribution of genetic variants, especiallyPNPLA3rs738409, as potential predictors for ACrelated HCC has been frequently discussed mainly because ORs often are > 2, calculated in retrospective cohorts[46]. However, modest to large ORs and extreme statistical significance do not automatically imply clinical relevance and other statistical metrics such as sensitivity, specificity and negative/positive predictive values might be more relevant[87]. Although variants inPNPLA3,TM6SF2and more recentlyHSD17B13modulate the risk of AC-related HCC, the use of these variants in HCC surveillance programs is currently not recommended[25,26].

    Even though predictive models for HCC have generally been successful, they have limited clinical utility currently, especially the use of genetic-based factors identified in one ethnic population but used for prediction in another population. Although recent use of PRS for identification/stratification of at-risk patients is promising, one important limitation of PRS is their applicability in non-European ancestry populations. Indeed, most of the variants used in PRS have been identified in GWAS overwhelmingly conducted in individuals of European descent[88]. Therefore, the applicability of current PRS is not guaranteed[89]. Failure to include individuals from diverse ancestry will hamper the use of PRS in the multiethnic population seen in clinical practice[90]. At the level of gene expression, a 186-gene signature,initially developed to predict HCC recurrence in HCV-infected patients, has shown promising predictive ability for hepatocarcinogenesis in AC patients[91].

    A particular challenge with alcohol-related liver diseases, including HCC, is the complication of alcohol dependence in these patients. Only select patients with alcohol-related HCC undergo liver transplantation(LT). After LT, up to 50% of patients relapse to drinking with 20% returning to harmful drinking with potential recurrence of liver disease[92]. The heritability of alcohol dependence has previously been estimated to be 25%-50%, and variants in genes encoding alcohol metabolism enzymes (ADH, ALDH)and GABA neurotransmission (GABRA2) have been shown to be associated with alcohol misuse[93].Whether these same markers can predict (beyond current clinical markers) recidivism post-LT is currently unknown, so this presents an opportunity for further study. Transplanted patients identified to be at high risk of relapse can be preferentially referred for participation in multidisciplinary relapse prevention programs, which have been shown to be effective[94]. The prediction of relapsers post-LT will be increasingly important as transplant indications have recently expanded to include select patients with severe alcoholic hepatitis without significant prior abstinence[95].

    Overall, PRS and gene expression signatures in combination with environmental risk factors have the potential to improve the prediction of alcohol-related HCC and pinpoint high-risk individuals. However,to date, evidence of clinical usefulness in this field is lacking. Thus, before genetic variation/expression can impact decision-making and be implemented in daily practice, it will need to be validated in large-scale prospective cohorts evaluating their clinical utility and cost-effectiveness[89,96]. Moreover, many physicians will require some training to interpret and communicate in a digestible manner the results of genetic testing and its current limitations[97].

    DECLARATIONS

    Authors’ contributions

    Led the overall concept, design, structure, writing, submission and revision of the manuscript in consultation with all co-authors: Seth D

    Risk stratification, HCC surveillance and treatment, Figure 1: Liu K

    Introduction, epidemiology of AC-HCC, risk prediction: Trepo E, Verset G

    Introduction, genetic variants, genetic variants risk prediction: Seth D

    All authors critically reviewed the manuscript.

    Availability of data and materials

    Not applicable.

    Financial support and sponsorship

    None.

    Conflicts of interest

    All authors declared that there are no conflicts of interest.

    Ethical approval and consent to participate

    Not applicable.

    Consent for publication

    Not applicable.

    Copyright

    ? The Author(s) 2020.

    404 Not Found

    404 Not Found


    nginx
    五月开心婷婷网| 人人妻人人澡人人看| 尾随美女入室| 国产又色又爽无遮挡免| 欧美av亚洲av综合av国产av| 亚洲欧美激情在线| 一级黄片播放器| 高清欧美精品videossex| 99久久99久久久精品蜜桃| 亚洲精品久久午夜乱码| 男女高潮啪啪啪动态图| 亚洲国产欧美在线一区| 久久久国产一区二区| 欧美国产精品一级二级三级| √禁漫天堂资源中文www| 国产激情久久老熟女| 美女扒开内裤让男人捅视频| 日本猛色少妇xxxxx猛交久久| 国产成人啪精品午夜网站| 久久久精品94久久精品| 男女国产视频网站| 国产精品 欧美亚洲| 欧美日韩亚洲国产一区二区在线观看 | 国产男人的电影天堂91| 国产精品偷伦视频观看了| 亚洲五月婷婷丁香| 超色免费av| 久久久久久久久久久久大奶| 亚洲av日韩在线播放| 午夜福利,免费看| 亚洲第一青青草原| 国产精品二区激情视频| 欧美人与善性xxx| 久久精品国产亚洲av涩爱| 亚洲国产精品999| www.av在线官网国产| 一二三四社区在线视频社区8| 亚洲,欧美精品.| 91麻豆精品激情在线观看国产 | 少妇猛男粗大的猛烈进出视频| 亚洲色图综合在线观看| 精品少妇久久久久久888优播| 高潮久久久久久久久久久不卡| xxxhd国产人妻xxx| 欧美日韩视频高清一区二区三区二| 久久久国产一区二区| 精品一区在线观看国产| 国产男女内射视频| 免费av中文字幕在线| 黑人欧美特级aaaaaa片| 黄色怎么调成土黄色| 丰满少妇做爰视频| 午夜91福利影院| 男男h啪啪无遮挡| 一本大道久久a久久精品| 欧美日韩av久久| 97精品久久久久久久久久精品| 亚洲中文字幕日韩| 婷婷成人精品国产| 亚洲 国产 在线| 亚洲国产毛片av蜜桃av| 午夜福利视频在线观看免费| av在线app专区| 亚洲成人免费av在线播放| 国产野战对白在线观看| 巨乳人妻的诱惑在线观看| 亚洲欧美色中文字幕在线| 亚洲成人免费av在线播放| 亚洲欧美清纯卡通| 人妻人人澡人人爽人人| 老司机亚洲免费影院| 在线 av 中文字幕| 久久人人爽人人片av| 日韩 亚洲 欧美在线| 一级a爱视频在线免费观看| 亚洲精品一卡2卡三卡4卡5卡 | 中文字幕色久视频| 久久久国产一区二区| 午夜激情久久久久久久| 91麻豆av在线| 欧美另类一区| 久久热在线av| 国产av国产精品国产| 亚洲精品国产一区二区精华液| 亚洲精品国产一区二区精华液| 9色porny在线观看| 国产精品一区二区免费欧美 | 日本av手机在线免费观看| 精品少妇久久久久久888优播| 国产在视频线精品| 无限看片的www在线观看| 97精品久久久久久久久久精品| 亚洲欧美激情在线| 每晚都被弄得嗷嗷叫到高潮| 亚洲精品一区蜜桃| 国产成人系列免费观看| 赤兔流量卡办理| 91精品三级在线观看| 亚洲人成77777在线视频| 国产女主播在线喷水免费视频网站| 免费高清在线观看视频在线观看| av福利片在线| 99热网站在线观看| 丰满人妻熟妇乱又伦精品不卡| 午夜免费鲁丝| 丝袜美足系列| 99国产精品一区二区三区| 久久国产精品影院| 国产欧美日韩一区二区三区在线| 亚洲少妇的诱惑av| 91麻豆精品激情在线观看国产 | 中文字幕av电影在线播放| 夜夜骑夜夜射夜夜干| 亚洲熟女毛片儿| 嫩草影视91久久| 久久精品熟女亚洲av麻豆精品| 欧美黄色片欧美黄色片| 国产精品一区二区在线观看99| 久久99一区二区三区| 免费人妻精品一区二区三区视频| 日本色播在线视频| 爱豆传媒免费全集在线观看| 久久午夜综合久久蜜桃| 免费一级毛片在线播放高清视频 | 性色av一级| 在线亚洲精品国产二区图片欧美| 新久久久久国产一级毛片| 国产午夜精品一二区理论片| 色94色欧美一区二区| 老司机影院成人| 精品熟女少妇八av免费久了| 国产成人精品无人区| 天天添夜夜摸| 欧美日韩福利视频一区二区| 黄色 视频免费看| 亚洲免费av在线视频| 一级毛片黄色毛片免费观看视频| 女人被躁到高潮嗷嗷叫费观| 在线亚洲精品国产二区图片欧美| 国产成人欧美| 欧美中文综合在线视频| 久久久久久久久免费视频了| 午夜91福利影院| 国产黄色视频一区二区在线观看| 久久久精品区二区三区| av天堂在线播放| 男女无遮挡免费网站观看| 欧美老熟妇乱子伦牲交| 亚洲人成77777在线视频| 久久久亚洲精品成人影院| 亚洲人成电影免费在线| 国产男人的电影天堂91| 大码成人一级视频| 日本av手机在线免费观看| 女性被躁到高潮视频| 在线观看www视频免费| 国产日韩欧美在线精品| 欧美人与善性xxx| 国产熟女欧美一区二区| 国产成人精品久久二区二区91| 久9热在线精品视频| av片东京热男人的天堂| 国产高清国产精品国产三级| 国产精品久久久久成人av| 丝袜在线中文字幕| tube8黄色片| 亚洲,欧美精品.| 欧美激情高清一区二区三区| 欧美日韩成人在线一区二区| 免费不卡黄色视频| 两个人看的免费小视频| 午夜福利影视在线免费观看| 国产黄色视频一区二区在线观看| 久久人人97超碰香蕉20202| 久久亚洲精品不卡| 精品久久久久久久毛片微露脸 | 欧美日韩av久久| 精品人妻1区二区| 免费在线观看完整版高清| 51午夜福利影视在线观看| 99香蕉大伊视频| www.精华液| 亚洲欧美清纯卡通| 天天躁夜夜躁狠狠躁躁| 国产一卡二卡三卡精品| 久久国产精品大桥未久av| 后天国语完整版免费观看| 一边亲一边摸免费视频| 亚洲中文日韩欧美视频| 一边摸一边做爽爽视频免费| videos熟女内射| 19禁男女啪啪无遮挡网站| 久久99精品国语久久久| 国产精品三级大全| 中文字幕精品免费在线观看视频| 嫩草影视91久久| 久久av网站| 满18在线观看网站| 18禁黄网站禁片午夜丰满| 搡老乐熟女国产| 久久久久网色| 乱人伦中国视频| 老汉色av国产亚洲站长工具| 99国产精品一区二区蜜桃av | 国产精品久久久久久精品电影小说| 免费看av在线观看网站| 久久久久久免费高清国产稀缺| 新久久久久国产一级毛片| 免费女性裸体啪啪无遮挡网站| 国产精品久久久久久人妻精品电影 | 免费观看a级毛片全部| 国产三级黄色录像| 欧美 日韩 精品 国产| 欧美日韩一级在线毛片| 一边摸一边做爽爽视频免费| www.自偷自拍.com| 天天影视国产精品| a级片在线免费高清观看视频| 国产一区有黄有色的免费视频| 狠狠精品人妻久久久久久综合| 国产在线一区二区三区精| 丝袜喷水一区| 久久毛片免费看一区二区三区| 国产亚洲欧美在线一区二区| 欧美激情高清一区二区三区| 色94色欧美一区二区| 男女下面插进去视频免费观看| 日韩av不卡免费在线播放| 欧美亚洲 丝袜 人妻 在线| 成人手机av| 亚洲av男天堂| 久久人人爽av亚洲精品天堂| 99九九在线精品视频| 久久人人爽人人片av| 新久久久久国产一级毛片| 亚洲国产日韩一区二区| 欧美在线一区亚洲| 欧美亚洲 丝袜 人妻 在线| 久久久久视频综合| 91老司机精品| 亚洲一区中文字幕在线| 三上悠亚av全集在线观看| 久久久精品免费免费高清| 人人妻人人爽人人添夜夜欢视频| 久久精品人人爽人人爽视色| 国产免费福利视频在线观看| 国产熟女午夜一区二区三区| 在线av久久热| 91精品伊人久久大香线蕉| 下体分泌物呈黄色| 亚洲图色成人| 91麻豆精品激情在线观看国产 | 男男h啪啪无遮挡| 在现免费观看毛片| 韩国精品一区二区三区| 久久人人爽人人片av| 极品少妇高潮喷水抽搐| 亚洲国产日韩一区二区| 国产精品久久久久久人妻精品电影 | 国产97色在线日韩免费| 啦啦啦中文免费视频观看日本| 国产成人a∨麻豆精品| 99国产精品一区二区三区| 国产免费又黄又爽又色| 亚洲黑人精品在线| 一本色道久久久久久精品综合| 50天的宝宝边吃奶边哭怎么回事| www日本在线高清视频| 91字幕亚洲| 亚洲成人国产一区在线观看 | 一级毛片女人18水好多 | 久久人妻福利社区极品人妻图片 | www日本在线高清视频| 精品人妻一区二区三区麻豆| 国产又色又爽无遮挡免| 大型av网站在线播放| 日本vs欧美在线观看视频| 丁香六月欧美| 欧美精品亚洲一区二区| 精品人妻1区二区| 日韩,欧美,国产一区二区三区| 亚洲久久久国产精品| 视频在线观看一区二区三区| 亚洲熟女精品中文字幕| 一本—道久久a久久精品蜜桃钙片| 久久青草综合色| 亚洲精品第二区| 精品亚洲成a人片在线观看| 高清视频免费观看一区二区| 亚洲七黄色美女视频| 免费人妻精品一区二区三区视频| 日本猛色少妇xxxxx猛交久久| 久久国产亚洲av麻豆专区| 亚洲欧美日韩另类电影网站| 在线观看人妻少妇| 女性生殖器流出的白浆| 别揉我奶头~嗯~啊~动态视频 | 菩萨蛮人人尽说江南好唐韦庄| 欧美久久黑人一区二区| 精品福利观看| videos熟女内射| 国产一区二区三区综合在线观看| 国产精品成人在线| 日本猛色少妇xxxxx猛交久久| 国产成人精品久久二区二区免费| 久久久久久久大尺度免费视频| 国产伦理片在线播放av一区| 一级片免费观看大全| 操美女的视频在线观看| 久久青草综合色| 国产黄色视频一区二区在线观看| av视频免费观看在线观看| 久久精品成人免费网站| 2018国产大陆天天弄谢| 又黄又粗又硬又大视频| 久久久久久久国产电影| 超碰成人久久| 国产深夜福利视频在线观看| 国产成人一区二区在线| 色精品久久人妻99蜜桃| 首页视频小说图片口味搜索 | 考比视频在线观看| 18在线观看网站| 久久久久精品国产欧美久久久 | 国产精品 欧美亚洲| 国产老妇伦熟女老妇高清| h视频一区二区三区| 久久免费观看电影| 成人18禁高潮啪啪吃奶动态图| 少妇 在线观看| 少妇精品久久久久久久| 欧美xxⅹ黑人| 国产精品 欧美亚洲| 欧美日韩精品网址| 久久久欧美国产精品| 国产成人影院久久av| 美女扒开内裤让男人捅视频| 亚洲欧美一区二区三区国产| 国产精品久久久人人做人人爽| 亚洲激情五月婷婷啪啪| 搡老乐熟女国产| 亚洲欧美中文字幕日韩二区| 十八禁高潮呻吟视频| 黄频高清免费视频| 欧美大码av| 少妇粗大呻吟视频| 亚洲av日韩精品久久久久久密 | 两人在一起打扑克的视频| av国产精品久久久久影院| 悠悠久久av| 午夜福利,免费看| 日韩一本色道免费dvd| 中文字幕最新亚洲高清| 日韩中文字幕欧美一区二区 | 日本猛色少妇xxxxx猛交久久| 国产精品99久久99久久久不卡| 精品视频人人做人人爽| a级毛片在线看网站| 熟女少妇亚洲综合色aaa.| 亚洲午夜精品一区,二区,三区| 欧美97在线视频| 久久久亚洲精品成人影院| 欧美中文综合在线视频| 国产老妇伦熟女老妇高清| 亚洲精品久久成人aⅴ小说| 日韩av在线免费看完整版不卡| 激情五月婷婷亚洲| 欧美成人午夜精品| 国产精品国产av在线观看| 在线观看免费日韩欧美大片| 久久久久久久久免费视频了| 悠悠久久av| 色94色欧美一区二区| 一本色道久久久久久精品综合| a 毛片基地| 亚洲第一青青草原| 国产欧美日韩综合在线一区二区| 欧美日韩国产mv在线观看视频| 午夜影院在线不卡| 亚洲精品日韩在线中文字幕| 精品少妇久久久久久888优播| 老熟女久久久| 性色av乱码一区二区三区2| 免费久久久久久久精品成人欧美视频| 少妇 在线观看| 国产欧美亚洲国产| 日本vs欧美在线观看视频| 亚洲国产精品成人久久小说| 80岁老熟妇乱子伦牲交| 久久九九热精品免费| 热re99久久国产66热| 天天影视国产精品| 只有这里有精品99| 好男人视频免费观看在线| 亚洲国产看品久久| 久久精品亚洲av国产电影网| 高清欧美精品videossex| 精品少妇黑人巨大在线播放| 色综合欧美亚洲国产小说| av线在线观看网站| 免费高清在线观看视频在线观看| 黄色毛片三级朝国网站| 高清视频免费观看一区二区| 啦啦啦在线观看免费高清www| 黑人巨大精品欧美一区二区蜜桃| av网站免费在线观看视频| 91精品国产国语对白视频| av视频免费观看在线观看| 如日韩欧美国产精品一区二区三区| 丝袜脚勾引网站| 国产熟女欧美一区二区| 亚洲中文日韩欧美视频| 在线精品无人区一区二区三| 高清av免费在线| 乱人伦中国视频| 久9热在线精品视频| 久久精品亚洲熟妇少妇任你| 亚洲成av片中文字幕在线观看| 亚洲国产av新网站| 欧美日韩黄片免| 久久人妻熟女aⅴ| 欧美久久黑人一区二区| 新久久久久国产一级毛片| 亚洲色图 男人天堂 中文字幕| 曰老女人黄片| www.av在线官网国产| 狂野欧美激情性xxxx| 日韩一区二区三区影片| 99精国产麻豆久久婷婷| 啦啦啦在线免费观看视频4| 91精品三级在线观看| 国产精品一区二区在线不卡| 午夜免费观看性视频| 成人三级做爰电影| av在线app专区| 两性夫妻黄色片| 99久久99久久久精品蜜桃| 亚洲第一av免费看| 成人18禁高潮啪啪吃奶动态图| 久久精品国产综合久久久| 亚洲,欧美精品.| 成人国产av品久久久| h视频一区二区三区| 精品国产乱码久久久久久小说| 欧美日韩av久久| 人人妻人人澡人人爽人人夜夜| 两个人看的免费小视频| 在线观看一区二区三区激情| 国产欧美日韩综合在线一区二区| 美女视频免费永久观看网站| 日韩一本色道免费dvd| 在线观看免费高清a一片| 精品一品国产午夜福利视频| 日本av免费视频播放| 老司机影院成人| 国产男女超爽视频在线观看| av一本久久久久| 日本五十路高清| 日韩大码丰满熟妇| 亚洲成人手机| 少妇被粗大的猛进出69影院| 18禁黄网站禁片午夜丰满| a级毛片黄视频| 19禁男女啪啪无遮挡网站| 久久人人爽av亚洲精品天堂| 国产免费又黄又爽又色| 欧美日韩福利视频一区二区| 又紧又爽又黄一区二区| 国产精品一区二区在线观看99| 日本黄色日本黄色录像| 国产精品av久久久久免费| av天堂久久9| 国产日韩欧美亚洲二区| 嫁个100分男人电影在线观看 | 蜜桃在线观看..| 777米奇影视久久| 国产野战对白在线观看| 亚洲精品久久久久久婷婷小说| 国语对白做爰xxxⅹ性视频网站| 欧美黄色片欧美黄色片| 十分钟在线观看高清视频www| 日韩中文字幕欧美一区二区 | 日日夜夜操网爽| 天天影视国产精品| 亚洲一卡2卡3卡4卡5卡精品中文| 精品福利观看| 国产精品一区二区在线观看99| 国产高清videossex| 涩涩av久久男人的天堂| 两性夫妻黄色片| 在现免费观看毛片| 亚洲中文av在线| 在线观看国产h片| 久久久国产欧美日韩av| 香蕉国产在线看| 狂野欧美激情性bbbbbb| 亚洲九九香蕉| 日日爽夜夜爽网站| 国产精品国产av在线观看| 爱豆传媒免费全集在线观看| 丝袜在线中文字幕| 日韩av不卡免费在线播放| 国语对白做爰xxxⅹ性视频网站| 亚洲av美国av| 免费久久久久久久精品成人欧美视频| 日本91视频免费播放| 日本午夜av视频| 777久久人妻少妇嫩草av网站| 免费高清在线观看日韩| 久久人人爽av亚洲精品天堂| 精品国产一区二区三区四区第35| 久久精品久久久久久噜噜老黄| 99热全是精品| 国产成人精品无人区| 亚洲av片天天在线观看| 一二三四社区在线视频社区8| 国产男女内射视频| 黑人巨大精品欧美一区二区蜜桃| 中文欧美无线码| 亚洲精品一卡2卡三卡4卡5卡 | 亚洲精品一区蜜桃| 亚洲一卡2卡3卡4卡5卡精品中文| 午夜两性在线视频| 亚洲国产欧美一区二区综合| 精品少妇久久久久久888优播| 午夜福利一区二区在线看| 首页视频小说图片口味搜索 | 青草久久国产| 777久久人妻少妇嫩草av网站| 欧美xxⅹ黑人| 99九九在线精品视频| 岛国毛片在线播放| 丰满迷人的少妇在线观看| a级片在线免费高清观看视频| 成人三级做爰电影| 十八禁高潮呻吟视频| 精品熟女少妇八av免费久了| 亚洲三区欧美一区| 亚洲av欧美aⅴ国产| 欧美 亚洲 国产 日韩一| 久久女婷五月综合色啪小说| 看免费av毛片| 免费在线观看完整版高清| svipshipincom国产片| 久久国产精品男人的天堂亚洲| 菩萨蛮人人尽说江南好唐韦庄| 久久久久久人人人人人| 免费人妻精品一区二区三区视频| 午夜激情av网站| 国产成人精品久久久久久| 国产在视频线精品| 人人妻人人澡人人爽人人夜夜| 脱女人内裤的视频| 欧美人与善性xxx| 久久人人爽av亚洲精品天堂| 国产一卡二卡三卡精品| 亚洲欧洲日产国产| 亚洲第一av免费看| 可以免费在线观看a视频的电影网站| 精品人妻一区二区三区麻豆| 国产成人av教育| 午夜精品国产一区二区电影| 后天国语完整版免费观看| 一区二区三区激情视频| 嫁个100分男人电影在线观看 | 久久精品国产亚洲av高清一级| 精品久久久精品久久久| 夫妻性生交免费视频一级片| 美女福利国产在线| 大香蕉久久网| 啦啦啦视频在线资源免费观看| 老汉色av国产亚洲站长工具| 黄片播放在线免费| 午夜福利,免费看| 高潮久久久久久久久久久不卡| 国产91精品成人一区二区三区 | 欧美97在线视频| 亚洲综合色网址| 亚洲国产看品久久| 国产男女内射视频| 国语对白做爰xxxⅹ性视频网站| 午夜福利免费观看在线| 精品国产国语对白av| 黄频高清免费视频| 亚洲专区国产一区二区| 成人黄色视频免费在线看| 亚洲av在线观看美女高潮| 在线av久久热| 亚洲成人免费av在线播放| 成人国产av品久久久| 亚洲黑人精品在线| a 毛片基地| 亚洲精品自拍成人| 久久人人爽人人片av| 欧美日韩成人在线一区二区| 亚洲熟女毛片儿| 日本av免费视频播放| 黄色 视频免费看| 操出白浆在线播放| 国产日韩欧美亚洲二区| 国产成人免费观看mmmm| 欧美av亚洲av综合av国产av| 婷婷丁香在线五月| avwww免费| 国产片内射在线| 久久av网站| 日日夜夜操网爽| 色94色欧美一区二区| 丰满少妇做爰视频| 最近最新中文字幕大全免费视频 | 美女脱内裤让男人舔精品视频| 亚洲欧美清纯卡通| 亚洲av日韩在线播放| 成年人午夜在线观看视频| 婷婷色麻豆天堂久久|